During this Fall’s Genome Startup Day event, we welcomed researchers and entrepreneurs that have taken the plunge into commercializing their phage discoveries. John Eisen, PhD, UC Davis professor and renowned genomics and microbiology researcher, spoke with Ivan Liachko, PhD, Founder and CEO for Phase Genomics, for a candid and lively fireside chat on the... Read more »

  Genome sequencing has confirmed some long-held theories about the blueprints of life. But it has also unearthed quite a few surprises. Scientists once hypothesized that the human genome consisted of upward of 100,000 genes. The decades-long Human Genome Project — as well as many next-generation sequencing studies — have prompted the downward revision of... Read more »

Stories from Startup Founders and an Insider’s Advice on SBIR Grants    Some of tomorrow’s biggest breakthroughs in cancer treatment are in the works today in startup labs across the US. On March 30th, we brought together CEOs and leaders in the cancer startup industry for a behind-the-scenes look at how emerging technologies are taking... Read more »

  Happy Women’s History Month! Being in the biotech industry and working with a strong, diverse team of scientists, we want to take a moment to reflect on the history of women in science and how we can make a brighter history for future generations. This past month, we shared stories from women at Phase... Read more »

  Since its debut, next-generation sequencing has not rested on its laurels. Improved sequencing platforms have reduced error and lengthened reads into the tens of thousands of bases. The debut of ultra-long-range sequencing methods that are based on proximity ligation (aka Hi-C) has brought a new order-of-magnitude into reach by linking DNA strands with their neighbors... Read more »

  A look back at the year 2021. The 21st year of the 21st century (a golden year, perhaps?) has come to an end. Looking back on the year that was abundant in vaccinations, canceled vacations, and virtual conferences, we would like to highlight the achievements that were made despite continuing challenges that face our... Read more »

  Phase Genomics’ recent release of the RUO cytogenomics platform, CytoTerra™, was accompanied by a webinar which covered an in-depth analysis of current technologies and emerging opportunities in reproductive genetics and oncology.     “The genome is the blueprint of life,” beginning the webinar, Ivan Liachko describes Phase Genomics’ history of discoveries and contributions to... Read more »

  “The microbiome is a very special opportunity because it allows you to create products that potentially have the efficacy of a drug, but the safety of a probiotic” -Colleen Cutcliffe, PhD   The Fall 2021 Genome Startup Day event, Inside the Microbiome, took a deep dive into the origins of several microbiome startups. Starting... Read more »

    Over 100 scientific papers have been published using Phase Genomics technology!   Since our founding in 2015, we have sought to bring transformative change to research, industry, and the clinic by building and providing cutting-edge genomic solutions to scientists all over the globe. Now, in 2021, we are happy to look back at... Read more »

  Metagenomic studies are illuminating the diverse array of microbiomes that exist from the ocean floor to our gastrointestinal tracts. Understanding these microbial communities is essential to understanding modern health and the environment; however, outdated lab techniques are laborious, costly, and fail to create a complete picture of the microbiome. This article, posted by Ivan... Read more »